Literature DB >> 10639389

In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.

J Meletiadis1, J W Mouton, J L Rodriguez-Tudela, J F Meis, P E Verweij.   

Abstract

In order to develop new approaches for the chemotherapy of invasive infections caused by Scedosporium prolificans, the in vitro interaction between itraconazole and terbinafine against 20 clinical isolates was studied using a checkerboard microdilution method. Itraconazole and terbinafine alone were inactive against most isolates, but the combination was synergistic against 95 and 85% of isolates after 48 and 72 h of incubation, respectively. Antagonism was not observed. The MICs obtained with the terbinafine-itraconazole combination were within levels that can be achieved in plasma.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10639389      PMCID： PMC89710          DOI： 10.1128/AAC.44.2.470-472.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds.

Authors:  M Del Poeta; W A Schell; J R Perfect
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Systemic availability of itraconazole in lung transplantation.

Authors:  T F Patterson; J Peters; S M Levine; A Anzueto; C L Bryan; E Y Sako; O L Miller; J H Calhoon; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Scedosporium apiospermum pneumonia after autologous bone marrow transplantation.

Authors:  M I García-Arata; M J Otero; M Zomeño; M A de la Figuera; M C de las Cuevas; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

4.  Oral terbinafine for treatment of pulmonary Pseudallescheria boydii infection refractory to itraconazole therapy.

Authors:  P E Verweij; N J Cox; J F Meis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

5.  In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.

Authors:  F Barchiesi; L Falconi Di Francesco; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

6.  Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.

Authors:  H O Hallander; K Dornbusch; L Gezelius; K Jacobson; I Karlsson
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

7.  Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

Authors:  M Cuenca-Estrella; B Ruiz-Díez; J V Martínez-Suárez; A Monzón; J L Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  1999-01       Impact factor: 5.790

8.  Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests.

Authors:  B Jahn; A Stüben; S Bhakdi
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

9.  Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.

Authors:  T J Walsh; J Peter; D A McGough; A W Fothergill; M G Rinaldi; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

10.  Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites.

Authors:  J M Kovarik; E A Mueller; H Zehender; J Denouël; H Caplain; L Millerioux
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191
View more
  30 in total

1.  Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

Authors:  B P Howden; M A Slavin; A P Schwarer; A M Mijch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-14       Impact factor: 3.267

2.  In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.

Authors:  C B Moore; C M Walls; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

4.  In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.

Authors:  Juliana S Argenta; Janio M Santurio; Sydney H Alves; Daniela I B Pereira; Ayrton S Cavalheiro; Andréia Spanamberg; Laerte Ferreiro
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

5.  In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.

Authors:  Joseph Meletiadis; Jacques F G M Meis; Johan W Mouton; Juan Luis Rodriquez-Tudela; J Peter Donnelly; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

6.  Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus.

Authors:  Joseph Meletiadis; Spyros Pournaras; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

7.  In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.

Authors:  Javier Afeltra; Eric Dannaoui; Jacques F G M Meis; Juan L Rodriguez-Tudela; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  In vitro susceptibility of environmental isolates of Exophiala dermatitidis to five antifungal drugs.

Authors:  Ana Paula Miranda Duarte; Fernando Carlos Pagnocca; Noemi Carla Baron; Marcia de Souza Carvalho Melhem; Gislene Aparecida Palmeira; Dejanira de Franceschi de Angelis; Derlene Attili-Angelis
Journal:  Mycopathologia       Date:  2012-11-16       Impact factor: 2.574

Review 9.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

10.  In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.

Authors:  Francesco Barchiesi; Elisabetta Spreghini; Monia Maracci; Annette W Fothergill; Isabella Baldassarri; Michael G Rinaldi; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.